Antidepressant shows promise for sickle cell disease

02/20/2013 | MedicalDaily.com

The antidepressant tranylcypromine was able to stop a mechanism that leads to the development of sickle cell disease in laboratory tests, according to a study in the journal Nature Genetics. The drug allowed the production of fetal hemoglobin in tests of human cells and animals, researchers said.

View Full Article in:

MedicalDaily.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Assistant General Counsel
Cardinal Health
Columbus, OH
Regulatory Affairs Specialist
Stryker
Mahwah, NJ
Sr. Principal OptoMechanical Engineer - 14000008M2
Abbott
San Jose, CA
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA